Survey quantifies COVID-19’s impact on oncologySeptember 20, 2020Breast CancerLung CancerLeukemia, Myelodysplasia, TransplantationHead & Neck/Thyroid CancersGenitourinary CancerMelanomaLymphoma & Plasma Cell Disorders
HPV-Mediated Head, Neck Cancers Predicted to Rise for DecadesSeptember 18, 2020Head & Neck/Thyroid Cancers
COVID-19 prompts ‘democratization’ of cancer trialsSeptember 16, 2020Genitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanomaOncology
Tailored messaging needed to get cancer screening back on trackAugust 24, 2020Breast CancerGenitourinary Cancer
Artificial intelligence matches cancer genotypes to patient phenotypesAugust 10, 2020Breast CancerLung CancerMelanomaHead & Neck/Thyroid CancersGenitourinary CancerOncology
Study: Immune checkpoint inhibitors don’t increase risk of death in cancer patients with COVID-19August 7, 2020Lung CancerMelanomaGenitourinary CancerOncology
Better continence rate gives robotic prostatectomy the edgeJuly 31, 2020Genitourinary CancerProstate CancerOncology
Higher death rate seen in cancer patients with nosocomial COVID-19July 30, 2020OncologyLung CancerLymphoma & Plasma Cell DisordersGenitourinary Cancer
